Economic Evaluation of Pharmaceuticals Michael F. Drummond Leading Article 13 November 2012 Pages: 8 - 13
Principles of Pharmacoeconomic Analysis of Drug Therapy Deborah A. FreundRobert S. Dittus Review Article 13 November 2012 Pages: 20 - 29
Pharmacoeconomic Evaluation of Risk Factors for Cardiovascular Disease Astrid E. FletcherChristopher J. Bulpitt Review Article 13 November 2012 Pages: 33 - 44
Pharmacoeconomics of Genetically Engineered Drugs Amy J. Jones-GrizzleJ. Lyle Bootman Review Article 13 November 2012 Pages: 45 - 53
Economic Analysis as an Aid to Subsidisation Decisions David Henry Review Article 13 November 2012 Pages: 54 - 67
Idarubicin More Cost-Effective than Daunorubicin? Alan L. Hillman Current Comment 13 November 2012 Pages: 68 - 69
Economic Cost of Asthma Substantial in NSW Douglas Coyle Current Comment 13 November 2012 Pages: 69 - 70
Total Costs of HIV Disease Higher with Zidovudine? Stephen T. Chambers Current Comment 13 November 2012 Pages: 70 - 71